A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban.

Charles Frost,Yan Song,Yu Chen Barrett,Jessie Wang,Janice Pursley,Rebecca A. Boyd,Frank P. LaCreta

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban.

2014

Charles Frost
Yan Song
Yu Chen Barrett
Jessie Wang
Janice Pursley
Rebecca A. Boyd
Frank P. LaCreta

Background Currently, there are no direct comparisons of apixaban and rivaroxaban, two new oral direct factor Xa inhibitors approved for management of thromboembolic disorders.

Keywords:

Direct factor Xa inhibitors
Apixaban
Rivaroxaban
Pharmacology
Pharmacokinetics
Medicine
Pharmacodynamics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations